These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17912871)

  • 21. Renin inhibition: should it supplant ACE inhibitors and ARBS in high risk patients?
    Gaddam KK; Oparil S
    Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):484-90. PubMed ID: 18695389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aliskiren, the first in a new class of direct renin inhibitors for hypertension: present and future perspectives.
    Oh BH
    Expert Opin Pharmacother; 2007 Nov; 8(16):2839-49. PubMed ID: 17956203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A study of the pharmacokinetic interactions of the direct renin inhibitor aliskiren with metformin, pioglitazone and fenofibrate in healthy subjects.
    Vaidyanathan S; Maboudian M; Warren V; Yeh CM; Dieterich HA; Howard D; Dole WP
    Curr Med Res Opin; 2008 Aug; 24(8):2313-26. PubMed ID: 18786303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A study of the pharmacokinetic interactions of the direct renin inhibitor aliskiren with allopurinol, celecoxib and cimetidine in healthy subjects.
    Ayalasomayajula S; Tchaloyan S; Yeh CM; Bizot MN; Dieterich HA; Howard D; Dole WP
    Curr Med Res Opin; 2008 Mar; 24(3):717-26. PubMed ID: 18234150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aliskiren/hydrochlorothiazide (Tekturna HCT) for hypertension.
    Med Lett Drugs Ther; 2008 Aug; 50(1293):65-6. PubMed ID: 18719523
    [No Abstract]   [Full Text] [Related]  

  • 26. Aliskiren as an alternative in a patient with life-threatening ACE inhibitor-induced angioedema.
    Anzaldua DA; Schmitz PG
    Am J Kidney Dis; 2008 Mar; 51(3):532-3. PubMed ID: 18295074
    [No Abstract]   [Full Text] [Related]  

  • 27. Aliskiren fails to lower blood pressure in patients who have either low PRA levels or whose PRA falls insufficiently or reactively rises.
    Sealey JE; Laragh JH
    Am J Hypertens; 2009 Jan; 22(1):112-21. PubMed ID: 18802434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renin inhibition in hypertension.
    Gradman AH; Kad R
    J Am Coll Cardiol; 2008 Feb; 51(5):519-28. PubMed ID: 18237679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Managing cardiovascular and renal risk: the potential of direct renin inhibition.
    Sever PS; Gradman AH; Azizi M
    J Renin Angiotensin Aldosterone Syst; 2009 Jun; 10(2):65-76. PubMed ID: 19502253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renin inhibitors: An important advance in hypertension treatment?
    Ferro A; Pitt B
    Int J Clin Pract; 2006 Nov; 60(11):1336-7. PubMed ID: 17073828
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacokinetics, safety, and tolerability of the oral Renin inhibitor aliskiren in patients with hepatic impairment.
    Vaidyanathan S; Warren V; Yeh C; Bizot MN; Dieterich HA; Dole WP
    J Clin Pharmacol; 2007 Feb; 47(2):192-200. PubMed ID: 17244770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renin inhibition: the holy grail of renin-angiotensin system blockade?
    McInnes GT
    J Hum Hypertens; 2007 Oct; 21(10):766-9. PubMed ID: 17541389
    [No Abstract]   [Full Text] [Related]  

  • 33. Aliskiren: clinical experience and future perspectives of renin inhibition.
    Sureshkumar KK; Vasudevan S; Marcus RJ; Hussain SM; McGill RL
    Expert Opin Pharmacother; 2008 Apr; 9(5):825-37. PubMed ID: 18345958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aliskiren: new drug. Arterial hypertension: no evidence of clinical efficacy.
    Prescrire Int; 2008 Apr; 17(94):47-50. PubMed ID: 18516803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension.
    Uresin Y; Taylor AA; Kilo C; Tschöpe D; Santonastaso M; Ibram G; Fang H; Satlin A
    J Renin Angiotensin Aldosterone Syst; 2007 Dec; 8(4):190-8. PubMed ID: 18205098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current concepts: renin inhibition in the treatment of hypertension.
    Gradman AH; Pinto R; Kad R
    Curr Opin Pharmacol; 2008 Apr; 8(2):120-6. PubMed ID: 18308634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A brief response to Sealey and Laragh.
    Hollenberg NK
    J Renin Angiotensin Aldosterone Syst; 2007 Jun; 8(2):53. PubMed ID: 17703429
    [No Abstract]   [Full Text] [Related]  

  • 38. A simple test to appreciate compliance to aliskiren treatment.
    Gosse P; Coulon P; Brossaud J; Corcuff JB
    J Hypertens; 2011 Oct; 29(10):2038. PubMed ID: 21904156
    [No Abstract]   [Full Text] [Related]  

  • 39. Total synthesis of "aliskiren": the first Renin inhibitor in clinical practice for hypertension.
    Hanessian S; Guesné S; Chénard E
    Org Lett; 2010 Apr; 12(8):1816-9. PubMed ID: 20235519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecule of the Month. Aliskiren fumarate.
    Drug News Perspect; 2006 Sep; 19(7):432. PubMed ID: 17080206
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.